Claims
- 1. A dispensing device for delivering a beneficial agent formulation to an environment of use, the dispensing device comprising
- (a) a wall that defines an internal space, said wall comprising in at least a part a composition that permits the passage of fluid;
- (b) a beneficial agent formulation in the space, said formulation comprising selenium;
- (c) an expandable composition in the space for urging the beneficial agent formulation from the device;
- (d) a layer of a composition comprising means for maintaining the identity of the beneficial agent formulation and the expandable composition in the space between the beneficial agent formulation and the expandable composition;
- (e) a density member in the space comprising a density for maintaining the device in the environment of use; and
- (f) exit means in the wall for dispensing the beneficial selenium to the environment of use over time.
- 2. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the selenium is a member selected from the group consisting of selenium disulfide and sodium selenite.
- 3. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the wall composition comprises cellulose acetate butyrate and cellulose acetate.
- 4. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the wall comprises cellulose acetate butyrate, cellulose acetate, tributyl citrate, triethyl citrate, and polyethylene glycol.
- 5. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the expandable composition comprises a member selected from the group consisting of carboxymethylcellulose and sodium carboxymethylcellulose.
- 6. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 1, wherein the expandable composition comprises sodium carboxymethylcellulose and sodium chloride.
- 7. A dispensing device for delivering a beneficial agent formulation to an environment of use, the dispensing device comprising:
- (a) a wall that defines an internal space, said wall comprising in at least a part a composition that permits the passage of fluid;
- (b) a beneficial agent formulation in the space, said formulation comprising selenium;
- (c) an expandable composition in the space for urging the beneficial agent formulation from the device, said expandable composition comprising a carboxyvinyl polymer;
- (d) a layer of a composition comprising means for maintaining the identity of the beneficial agent formulation and the expandable composition in the space between the beneficial agent formulation and the expandable composition;
- (e) a density member in the space comprising a density for maintaining the device in the environment of use; and
- (f) exit means in the wall for dispensing the beneficial selenium to the environment of use over time.
- 8. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 7, wherein the selenium is a member selected from the group consisting of selenium, selenium disulfide and sodium selenite.
- 9. A dispensing device for delivering the beneficial agent formulation to an environment of use according to claim 7, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.
- 10. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 7, wherein the wall comprises cellulose acetate butyrate, cellulose acetate, tributyl citrate, triethyl citrate and polyethylene glycol.
- 11. The dispensing device for delivering the beneficial agent to the environment of use according to claim 7, wherein the exit means comprises a plurality of pores.
- 12. A dispensing device for delivering a beneficial agent formulation to an environment of use the dispensing device comprising:
- (a) a wall that defines an internal space, said wall comprising in at least a part a composition that permits the passage of fluid;
- (b) a beneficial agent formulation in the space, said formulation comprising avermectin;
- (c) an expandable composition in the space for urging the beneficial agent formulation from the device;
- (d) a layer of a composition comprising means for maintaining the identity of the beneficial agent formulation and the expandable composition in the space between the beneficial agent formulation and the expandable composition;
- (e) a density member in the space comprising a density for maintaining the device in the environment of use; and
- (f) exit means in the wall for dispensing the beneficial avermectin to the environment of use over time.
- 13. A dispensing device for delivering the beneficial agent formulation to an environment of use according to claim 12, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.
- 14. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 12, wherein the wall comprises cellulose acetate butyrate, cellulose acetate, tributyl citate, triethyl citrate, and polyethylene glycol.
- 15. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 12 wherein the expandable composition comprises a member selected from the group consisting of carboxymethylcellulose and sodium carboxymethylcellulose.
- 16. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 12, wherein the expandable member comprises sodium carboxymethylcellulose and sodium chloride.
- 17. The dispensing device for delivering the beneficial agent to the environment of use according to claim 12, wherein the exit means comprises a plurality of pores.
- 18. The dispensing device for delivering the beneficial agent to the environment of use according to claim 12, wherein the avermectin is ivermectin.
- 19. A dispensing device for delivering a beneficial agent formulation to an environment of use, the dispensing device comprising:
- (a) a wall that defines an internal space, said wall comprising in at least a part a composition that permits the passage of fluid;
- (b) a beneficial agent formulation in the space, said formulation comprising avermectin;
- (c) an expandable composition in the space for urging the beneficial agent formulation from the device, said expandable composition comprising a carboxyvinyl polymer;
- (d) a layer of a composition comprising means for maintaining the identity of the beneficial agent formulation and the expandable composition in the space between the beneficial agent formulation and the expandable composition;
- (e) a density member in the space comprising a density for maintaining the device in the environment of use; and
- (f) exit means in the wall for dispensing the beneficial avermectin to the environment of use over time.
- 20. A dispensing device for delivering the beneficial agent formulation to an environment of use according to claim 19, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.
- 21. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the wall comprises cellulose acetate butyrate, cellulose acetate, tributyl citrate, triethyl citrate, and polyethylene glycol.
- 22. The dispensing device for delivering the beneficial agent formulation according to claim 19, wherein the carboxyvinyl polymer is a carboxypolymethylene polymer.
- 23. The dispensing device for delivering the beneficial agent formulation according to claim 19, wherein the carboxyvinyl polymer is a polymer of acrylic acid cross-linked with polyallyl sucrose.
- 24. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the expandable composition comprises carboxyvinyl polymer and sodium chloride.
- 25. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the expandable composition comprises carboxyvinyl polymer, sodium chloride, and polyvinyl pyrrolidone.
- 26. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the expandable composition comprises carboxyvinyl polymer, sodium chloride, polyvinyl pyrrolidone, and magnesium stearate.
- 27. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the exit means comprises a plurality of pores.
- 28. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 19, wherein the avermectin is ivermectin.
- 29. A dispensing device for delivering a beneficial agent to an environment of use, the dispensing device comprising:
- (a) a wall;
- (b) an internal lumen defined by the wall;
- (c) a beneficial agent formulation comprising a lasolocid in the lumen;
- (d) a composition in the lumen for pushing the beneficial agent formulation from the device;
- (e) a density member in the lumen comprising a density for maintaining the device in the environment of use; and,
- (f) exit means in the device for dispensing the beneficial lasolocid to the environment of use over time.
- 30. The dispensing device for delivering the beneficial agent formulation to the environment of use according to claim 29, wherein the composition for pushing the beneficial agent formulation comprises a member selected from the group consisting of carboxymethylcellulose, sodium carboxymethylcellulose, a composition comprising carboxymethylcellulose and sodium chloride, a composition comprising a carboxyvinyl polymer, sodium chloride and polyvinyl pyrrolidone, and a composition comprising a carboxyvinyl polymer, sodium chloride, polyvinyl pyrrolidone and magnesium stearate.
- 31. The dispensing device for delivering the beneficial agent to the environment of use according to claim 29, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.
- 32. The dispensing device for delivering the beneficial agent to the environment of use according to claim 29, wherein the wall comprises tributyl citrate and triethyl citrate.
- 33. A dispensing device for delivering a beneficial agent to an environment of use, the dispensing device comprising:
- (a) a wall;
- (b) an internal lumen defined by the wall;
- (c) a beneficial agent comprising an ionophere in the lumen;
- (d) means in the lumen for pushing the beneficial ionophere from the device;
- (e) means for maintaining the identity of the beneficial ionophere and the means for pushing the ionophere from the device, said means for maintaining the identity in the lumen between the beneficial ionophere and the means for pushing;
- (f) a density member in the lumen for maintaining the device in the environment of use; and,
- (g) exit means in the device for dispensing the beneficial ionophere to the environment of use over time.
- 34. The dispensing device for delivering the beneficial ionophere to the environment of use according to claim 33, wherein the means for pushing comprise a member selected from the group consisting of carboxymethylcellulose, sodium carboxymethylcellulose, a composition comprising carboxymethylcellulose and sodium chloride, a composition comprising a carboxyvinyl polymer, sodium chloride and polyvinyl pyrrolidone, and a composition comprising a carboxyvinyl polymer, sodium chloride, polyvinyl pyrrolidone and magnesium stearate.
- 35. The dispensing device for delivering the beneficial ionophere to the environment of use according to claim 33, wherein the wall comprises cellulose acetate butyrate and cellulose acetate.
- 36. The dispensing device for delivering the beneficial ionophere to the environment of use according to claim 33, wherein the wall comprises tributyl citrate and triethyl citrate.
- 37. The dispensing device for delivering the beneficial ionophere to the environment of use according to claim 33, wherein the ionophere is a member selected from the group consisting of lasalocid, salinomycin, virginiamycin and ronnel.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a division of U.S. patent application Ser. No. 06/902,916 filed Sept. 2, 1986 and now U.S. Pat. No. 4,729,793 issued Mar. 8, 1988, which application Ser. No. 06/902,916 is a CIP of U.S. patent application Ser. No. 06/764,143 filed Aug. 9, 1985 now U.S. Pat. No. 4,624,945 issued Nov. 25, 1986, which application Ser. No. 06/764,143 is a CIP of U.S. patent application Ser. No. 06/590,778 filed Mar. 19, 1984 and now U.S. Pat. No. 4,595,583 issued June 17, 1986. These applications are incorporated herein by reference and benefit is claimed of their filing dates. The applications are assigned to ALZA Corporation of Palo Alto, California.
US Referenced Citations (27)
Foreign Referenced Citations (3)
Number |
Date |
Country |
19250 |
Mar 1972 |
AUX |
2729068 |
Nov 1979 |
DEX |
1540258 |
Sep 1968 |
FRX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
902916 |
Sep 1986 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
764143 |
Aug 1985 |
|
Parent |
590778 |
Mar 1984 |
|